JPRN-UMIN000020402
Completed
未知
Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximab - Early use of infliximab in severe case and moderate case close to severe case of ulcerative colitis
IBD Relapse Prevention Team0 sites50 target enrollmentDecember 30, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- IBD Relapse Prevention Team
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •mild case, moderate case close to mild case
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Better control and treatment of Ulcerative Colitis (UC) by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsiesNL-OMON54471Radboud Universitair Medisch Centrum40
Recruiting
Phase 1
Study on the treatment of ulcerative colitis in mild to moderate active stage by removing dampnesslcerative colitisITMCTR2000003426Guangdong Provincial Hospital of Chinese Medicine
Active, not recruiting
Phase 1
SB012 for the treatment of active ulcerative colitis: a clinical study in early development (phase IIa), conducted in several study centres, with random assignment of patients to active treatment or placebo, to investigate the efficacy, pharmacokinetics, tolerability, and safety of SB012 enema administered once dailyActive ulcerative colitisTherapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]EUCTR2013-004599-36-DEsterna biologicals GmbH & Co. KG18
Recruiting
Phase 1
A novel treatment for ulcerative colitis with purastatlcerative colitisInflammatory bowel diseaseD003093JPRN-jRCTs032230119Hashimoto Yu20
Completed
Phase 3
Remission maintenance treatment of ulcerative colitis with tacrolimus in azathioprine-intolerant patients: a randomized comparative trial of 5-aminosalicylic acid (5-ASA) monotherapy versus 5-ASA and tacrolimus combination therapy.JPRN-UMIN000003785Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine80